Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Reconstructing the early global dynamics of under-ascertained COVID-19 cases and infections

View ORCID ProfileTimothy W. Russell, View ORCID ProfileNick Golding, View ORCID ProfileJoel Hellewell, View ORCID ProfileSam Abbott, Lawrence Wright, View ORCID ProfileCarl A B Pearson, View ORCID ProfileKevin van Zandvoort, View ORCID ProfileChristopher I Jarvis, View ORCID ProfileHamish Gibbs, View ORCID ProfileYang Liu, View ORCID ProfileRosalind M. Eggo, View ORCID ProfileW. John Edmunds, View ORCID ProfileAdam J. Kucharski on behalf of the CMMID COVID-19 working group
doi: https://doi.org/10.1101/2020.07.07.20148460
Timothy W. Russell
1Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Timothy W. Russell
  • For correspondence: timothy.russell@lshtm.ac.uk
Nick Golding
2Telethon Kids Institute and Curtin University, Perth, Western Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nick Golding
Joel Hellewell
1Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Joel Hellewell
Sam Abbott
1Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sam Abbott
Lawrence Wright
3Defence Science and Technology Laboratory/Sopra Steria, Fareham, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carl A B Pearson
1Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Carl A B Pearson
Kevin van Zandvoort
1Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kevin van Zandvoort
Christopher I Jarvis
1Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christopher I Jarvis
Hamish Gibbs
1Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hamish Gibbs
Yang Liu
1Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yang Liu
Rosalind M. Eggo
1Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rosalind M. Eggo
W. John Edmunds
1Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for W. John Edmunds
Adam J. Kucharski
1Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Adam J. Kucharski
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Asymptomatic or subclinical SARS-CoV-2 infections are often unreported, which means that confirmed case counts may not accurately reflect underlying epidemic dynamics. Understanding the level of ascertainment (the ratio of confirmed symptomatic cases to the true number of symptomatic individuals) and undetected epidemic progression is crucial to informing COVID-19 response planning, including the introduction and relaxation of control measures. Estimating case ascertainment over time allows for accurate estimates of specific outcomes such as seroprevalence, which is essential for planning control measures.

Methods Using reported data on COVID-19 cases and fatalities globally, we estimated the proportion of symptomatic cases (i.e. any person with any of fever >= 37.5°C, cough, shortness of breath, sudden onset of anosmia, ageusia or dysgeusia illness) that were reported in 210 countries and territories, given those countries had experienced more than ten deaths. We used published estimates of the baseline case fatality ratio (CFR), which was adjusted for delays and under-ascertainment, then calculated the ratio of this baseline CFR to an estimated local delay-adjusted CFR to estimate the level of under-ascertainment in a particular location. We then fit a Bayesian Gaussian process model to estimate the temporal pattern of under-ascertainment.

Results Based on reported cases and deaths, we estimated that, during March 2020, the median percentage of symptomatic cases detected across the 84 countries which experienced more than ten deaths ranged from 2.4% (Bangladesh) to 100% (Chile). Across the ten countries with the highest number of total confirmed cases as of 6th July 2020, we estimated that the peak number of symptomatic cases ranged from 1.4 times (Chile) to 18 times (France) larger than reported. Comparing our model with national and regional seroprevalence data where available, we find that our estimates are consistent with observed values. Finally, we estimated seroprevalence for each country. As of the 7th June, our seroprevalence estimates range from 0% (many countries) to 13% (95% CrI: 5.6% – 24%) (Belgium).

Conclusions We found substantial under-ascertainment of symptomatic cases, particularly at the peak of the first wave of the SARS-CoV-2 pandemic, in many countries. Reported case counts will therefore likely underestimate the rate of outbreak growth initially and underestimate the decline in the later stages of an epidemic. Although there was considerable under-reporting in many locations, our estimates were consistent with emerging serological data, suggesting that the proportion of each country’s population infected with SARS-CoV-2 worldwide is generally low.

Funding Wellcome Trust, Bill & Melinda Gates Foundation, DFID, NIHR, GCRF, ARC.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The following funding sources are acknowledged as providing funding for the named authors. This research was partly funded by the Bill & Melinda Gates Foundation (INV-003174: YL). DFID/Wellcome Trust (Epidemic Preparedness Coronavirus research programme 221303/Z/20/Z: KvZ). Elrha R2HC/UK DFID/Wellcome Trust/This research was partly funded by the National Institute for Health Research (NIHR) using UK aid from the UK Government to support global health research. The views expressed in this publication are those of the author(s) and not necessarily those of the NIHR or the UK Department of Health and Social Care (KvZ). This project has received funding from the European Union's Horizon 2020 research and innovation programme - project EpiPose (101003688: WJE, YL). This research was partly funded by the Global Challenges Research Fund (GCRF) project 'RECAP' managed through RCUK and ESRC (ES/P010873/1: CIJ). HDR UK (MR/S003975/1: RME). NIHR (16/137/109: YL). UK DHSC/UK Aid/NIHR (ITCRZ 03010: HPG). UK MRC (MC_PC_19065: RME, WJE, YL). Wellcome Trust (206250/Z/17/Z: AJK, TWR; 210758/Z/18/Z: JH, SA). NG was partially funded by an ARC DECRA fellowship (DE180100635) The following funding sources are acknowledged as providing funding for the working group authors. Alan Turing Institute (AE). BBSRC LIDP (BB/M009513/1: DS). This research was partly funded by the Bill & Melinda Gates Foundation (INV-001754: MQ; INV-003174: KP, MJ; NTD Modelling Consortium OPP1184344: CABP, GM; OPP1180644: SRP; OPP1183986: ESN; OPP1191821: KO'R, MA). DFID/Wellcome Trust (Epidemic Preparedness Coronavirus research programme 221303/Z/20/Z: CABP). DTRA (HDTRA1-18-1-0051: JWR). ERC Starting Grant (#757688: CJVA, KEA; #757699: JCE, RMGJH; 757699: MQ). This project has received funding from the European Union's Horizon 2020 research and innovation programme - project EpiPose (101003688: KP, MJ, PK). This research was partly funded by the Global Challenges Research Fund (GCRF) project 'RECAP' managed through RCUK and ESRC (ES/P010873/1: AG, TJ). Nakajima Foundation (AE). This research was partly funded by the National Institute for Health Research (NIHR) using UK aid from the UK Government to support global health research. The views expressed in this publication are those of the author(s) and not necessarily those of the NIHR or the UK Department of Health and Social Care (16/136/46: BJQ; 16/137/109: BJQ, CD, FYS, MJ; Health Protection Research Unit for Immunisation NIHR200929: NGD; Health Protection Research Unit for Modelling Methodology HPRU-2012-10096: TJ; NIHR200929: MJ; PR-OD-1017-20002: AR). Royal Society (Dorothy Hodgkin Fellowship: RL; RP\EA\180004: PK). UK MRC (LID DTP MR/N013638/1: GRGL, QJL; MC_PC_19065: AG, NGD, SC, TJ; MR/P014658/1: GMK). Authors of this research receive funding from UK Public Health Rapid Support Team funded by the United Kingdom Department of Health and Social Care (TJ). Wellcome Trust (206471/Z/17/Z: OJB; 208812/Z/17/Z: SC, SFlasche; 210758/Z/18/Z: JDM, KS, NIB, SFunk, SRM). No funding (AKD, AMF, DCT, SH).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

No applicable

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • CMMID COVID-19 working group members (order selected at random): Arminder K Deol, C Julian Villabona-Arenas, Thibaut Jombart, Kathleen O’Reilly, James D Munday, Sophie R Meakin, Rachel Lowe, Amy Gimma, Akira Endo, Emily S Nightingale, Graham Medley, Anna M Foss, Gwenan M Knight, Kiesha Prem, Stéphane Hué, Charlie Diamond, James W Rudge, Katherine E. Atkins, Megan Auzenbergs, Stefan Flasche, Rein M G J Houben, Billy J Quilty, Petra Klepac, Matthew Quaife, Sebastian Funk, Quentin J Leclerc, Jon C Emery, Mark Jit, David Simons, Nikos I Bosse, Simon R Procter, Fiona Yueqian Sun, Samuel Clifford, Katharine Sherratt, Alicia Rosello, Nicholas G. Davies, Oliver Brady, Damien C Tully, Georgia R Gore-Langton.

Data Availability

The data we use is publicly available online from the European Centre for Disease Control (ECDC) here: https://www.ecdc.europa.eu/en/publications-data/download-todays-data-geographic-distribution-covid-19-cases-worldwide.

https://www.ecdc.europa.eu/en/publications-data/download-todays-data-geographic-distribution-covid-19-cases-worldwide

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted September 22, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Reconstructing the early global dynamics of under-ascertained COVID-19 cases and infections
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Reconstructing the early global dynamics of under-ascertained COVID-19 cases and infections
Timothy W. Russell, Nick Golding, Joel Hellewell, Sam Abbott, Lawrence Wright, Carl A B Pearson, Kevin van Zandvoort, Christopher I Jarvis, Hamish Gibbs, Yang Liu, Rosalind M. Eggo, W. John Edmunds, Adam J. Kucharski
medRxiv 2020.07.07.20148460; doi: https://doi.org/10.1101/2020.07.07.20148460
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Reconstructing the early global dynamics of under-ascertained COVID-19 cases and infections
Timothy W. Russell, Nick Golding, Joel Hellewell, Sam Abbott, Lawrence Wright, Carl A B Pearson, Kevin van Zandvoort, Christopher I Jarvis, Hamish Gibbs, Yang Liu, Rosalind M. Eggo, W. John Edmunds, Adam J. Kucharski
medRxiv 2020.07.07.20148460; doi: https://doi.org/10.1101/2020.07.07.20148460

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (174)
  • Allergy and Immunology (421)
  • Anesthesia (97)
  • Cardiovascular Medicine (901)
  • Dentistry and Oral Medicine (170)
  • Dermatology (102)
  • Emergency Medicine (257)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (407)
  • Epidemiology (8783)
  • Forensic Medicine (4)
  • Gastroenterology (405)
  • Genetic and Genomic Medicine (1861)
  • Geriatric Medicine (178)
  • Health Economics (388)
  • Health Informatics (1290)
  • Health Policy (644)
  • Health Systems and Quality Improvement (491)
  • Hematology (207)
  • HIV/AIDS (394)
  • Infectious Diseases (except HIV/AIDS) (10557)
  • Intensive Care and Critical Care Medicine (564)
  • Medical Education (193)
  • Medical Ethics (52)
  • Nephrology (218)
  • Neurology (1754)
  • Nursing (103)
  • Nutrition (266)
  • Obstetrics and Gynecology (342)
  • Occupational and Environmental Health (461)
  • Oncology (964)
  • Ophthalmology (282)
  • Orthopedics (107)
  • Otolaryngology (176)
  • Pain Medicine (117)
  • Palliative Medicine (43)
  • Pathology (264)
  • Pediatrics (557)
  • Pharmacology and Therapeutics (264)
  • Primary Care Research (219)
  • Psychiatry and Clinical Psychology (1843)
  • Public and Global Health (3982)
  • Radiology and Imaging (654)
  • Rehabilitation Medicine and Physical Therapy (344)
  • Respiratory Medicine (535)
  • Rheumatology (215)
  • Sexual and Reproductive Health (178)
  • Sports Medicine (166)
  • Surgery (197)
  • Toxicology (37)
  • Transplantation (106)
  • Urology (80)